116
Participants
Start Date
July 31, 2010
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
Desmopressin
Desmopressin oral lyophilisate melt tablet, in either the 10, 25, 50, or 100 μg dosage, for sublingual administration
Placebo
Placebo melt tablet for sublingual administration
Japanese Red Cross Nagoya Daiichi Hospital, Nagoya
National Center for Geriatrics and Gerontology, Ōbu
Kokuho Asahi Central Hospital, Asahi
University of Fukui Hospital, Yoshida
Takayama Hospital, Chikushino-shi
Harasanshin Hospital, Fukuoka
Saku Hospital, Fukuoka
Southwest Urological Clinic, Fukuoka
Yakuin Urogenital Hospital, Fukuoka
Houshikai Group Kano Hospital, Koga
St. Mary's Hospital, Kurume
Fukushima Red Cross Hospital, Fukushima
Ohara General Hospital, Fukushima
Saiseikai Fukushima General Hospital, Fukushima
Jyusendo General Hospital, Kōriyama
Social Insurance Nihonmatsu Hospital, Nihommatsu
Takayama Clinic, Awagi
National Hospital Organization Kobe Medical Center, Kobe
Japanese Red Cross Mito Hospital, Mito
Jigenji Kubo Clinic, Kagoshima
Kawahara Hinyoukika, Kagoshima
Yagi Clinic, Kagoshima
Yokohama Shin-midori General Hospital, Yokohama
Kumamoto Rosai Hospital, Yatsushiro
Rakusai Newtown Hospital, Kyoto
Tohoku University Hospital, Sendai
Shinshu University Hospital, Matsumoto
Suzuki Urological Clinic, Nagano
Senbokufujii Hospital, Sakai
Nanri Urological Clinic, Saga
Kasukabe Chuo General Hospital, Kasukabe
Hamamatsu University School of Medicine University Hospital, Hamamatsu
Tokyo Women's Medical University Medical Center East, Arakawa City
Koganeibashi Sakura Clinic, Koganei
Kunitachi Sakura Hospital, Kunitachi
University of Yamanashi Hospital, Chūō
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY